Furthermore, synthetic TLR9-ligands (CpG-sequence containing oligonucleotides) have been demonstrated to stimulate the in vitro invasion of TLR9-expressing cancer cells, including astrocytoma and glioblastoma cells (14,16). The gene discussed is TLR9; the disease is astrocytoma (excluding glioblastoma).